Cargando…

Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study

OBJECTIVE: The survival value of systematic lymphadenectomy for endometrial cancer is ambiguous and controversial. The current study aimed to evaluate the long-term survival role of combined pelvic and para-aortic lymphadenectomy in patients with presumed early-stage clear cell carcinoma of the endo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yong, Ran, Lin, Liu, Yi, Xu, Yu, Shen, Juan, Mi, Gong-sheng, Ke, Feng-mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987355/
https://www.ncbi.nlm.nih.gov/pubmed/35402252
http://dx.doi.org/10.3389/fonc.2022.800957
_version_ 1784682722812231680
author Tian, Yong
Ran, Lin
Liu, Yi
Xu, Yu
Shen, Juan
Mi, Gong-sheng
Ke, Feng-mei
author_facet Tian, Yong
Ran, Lin
Liu, Yi
Xu, Yu
Shen, Juan
Mi, Gong-sheng
Ke, Feng-mei
author_sort Tian, Yong
collection PubMed
description OBJECTIVE: The survival value of systematic lymphadenectomy for endometrial cancer is ambiguous and controversial. The current study aimed to evaluate the long-term survival role of combined pelvic and para-aortic lymphadenectomy in patients with presumed early-stage clear cell carcinoma of the endometrium. METHODS: Patients in three Chinese teaching hospitals who presented between 2012 and 2017 with apparent early-stage clear cell carcinoma of the endometrium and underwent surgical staging were selected. Patients who did and did not undergo systematic lymphadenectomy were identified and clinicopathological characteristics were compared. Disease-free survival and overall survival were evaluated following the generation of the Kaplan-Meier curves and the comparison using the log-rank test. A Cox proportional hazards model was employed to control for confounders. RESULTS: A total of 244 patients underwent systematic lymphadenectomy and 89 did not receive lymph node dissection. The demographic and baseline data were comparable between the two groups. The rate of disease-free survival at 5 years was 64.10% in patients who underwent systematic lymphadenectomy and 45.05% in patients who did not undergo lymphadenectomy. Patients who underwent systematic lymphadenectomy had better disease-free survival than those who did not receive lymphadenectomy (HR, 0.54. 95% CI, 0.38-0.76. P=0.000). The rate of 5-year overall survival was 68.87% in the lymphadenectomy group and 53.33% in patients who did not undergo systematic lymphadenectomy. Systematic lymphadenectomy was also associated with improved 5-year overall survival for women with presumed early-stage clear cell carcinoma of the endometrium (HR, 0.58. 95% CI, 0.39-0.85. P=0.005). After adjusting for confounders, systematic lymphadenectomy was still independently associated with improved disease-free survival and overall survival. CONCLUSION: Patients with apparent early-stage clear cell carcinoma of the endometrium who underwent systematic lymphadenectomy had better long-term survival than those who did not undergo systematic lymphadenectomy.
format Online
Article
Text
id pubmed-8987355
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89873552022-04-08 Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study Tian, Yong Ran, Lin Liu, Yi Xu, Yu Shen, Juan Mi, Gong-sheng Ke, Feng-mei Front Oncol Oncology OBJECTIVE: The survival value of systematic lymphadenectomy for endometrial cancer is ambiguous and controversial. The current study aimed to evaluate the long-term survival role of combined pelvic and para-aortic lymphadenectomy in patients with presumed early-stage clear cell carcinoma of the endometrium. METHODS: Patients in three Chinese teaching hospitals who presented between 2012 and 2017 with apparent early-stage clear cell carcinoma of the endometrium and underwent surgical staging were selected. Patients who did and did not undergo systematic lymphadenectomy were identified and clinicopathological characteristics were compared. Disease-free survival and overall survival were evaluated following the generation of the Kaplan-Meier curves and the comparison using the log-rank test. A Cox proportional hazards model was employed to control for confounders. RESULTS: A total of 244 patients underwent systematic lymphadenectomy and 89 did not receive lymph node dissection. The demographic and baseline data were comparable between the two groups. The rate of disease-free survival at 5 years was 64.10% in patients who underwent systematic lymphadenectomy and 45.05% in patients who did not undergo lymphadenectomy. Patients who underwent systematic lymphadenectomy had better disease-free survival than those who did not receive lymphadenectomy (HR, 0.54. 95% CI, 0.38-0.76. P=0.000). The rate of 5-year overall survival was 68.87% in the lymphadenectomy group and 53.33% in patients who did not undergo systematic lymphadenectomy. Systematic lymphadenectomy was also associated with improved 5-year overall survival for women with presumed early-stage clear cell carcinoma of the endometrium (HR, 0.58. 95% CI, 0.39-0.85. P=0.005). After adjusting for confounders, systematic lymphadenectomy was still independently associated with improved disease-free survival and overall survival. CONCLUSION: Patients with apparent early-stage clear cell carcinoma of the endometrium who underwent systematic lymphadenectomy had better long-term survival than those who did not undergo systematic lymphadenectomy. Frontiers Media S.A. 2022-03-24 /pmc/articles/PMC8987355/ /pubmed/35402252 http://dx.doi.org/10.3389/fonc.2022.800957 Text en Copyright © 2022 Tian, Ran, Liu, Xu, Shen, Mi and Ke https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Tian, Yong
Ran, Lin
Liu, Yi
Xu, Yu
Shen, Juan
Mi, Gong-sheng
Ke, Feng-mei
Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
title Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
title_full Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
title_fullStr Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
title_full_unstemmed Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
title_short Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
title_sort systematic lymphadenectomy and oncological outcomes of women with apparent early-stage clear cell carcinoma of the endometrium: a multi-institutional cohort study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987355/
https://www.ncbi.nlm.nih.gov/pubmed/35402252
http://dx.doi.org/10.3389/fonc.2022.800957
work_keys_str_mv AT tianyong systematiclymphadenectomyandoncologicaloutcomesofwomenwithapparentearlystageclearcellcarcinomaoftheendometriumamultiinstitutionalcohortstudy
AT ranlin systematiclymphadenectomyandoncologicaloutcomesofwomenwithapparentearlystageclearcellcarcinomaoftheendometriumamultiinstitutionalcohortstudy
AT liuyi systematiclymphadenectomyandoncologicaloutcomesofwomenwithapparentearlystageclearcellcarcinomaoftheendometriumamultiinstitutionalcohortstudy
AT xuyu systematiclymphadenectomyandoncologicaloutcomesofwomenwithapparentearlystageclearcellcarcinomaoftheendometriumamultiinstitutionalcohortstudy
AT shenjuan systematiclymphadenectomyandoncologicaloutcomesofwomenwithapparentearlystageclearcellcarcinomaoftheendometriumamultiinstitutionalcohortstudy
AT migongsheng systematiclymphadenectomyandoncologicaloutcomesofwomenwithapparentearlystageclearcellcarcinomaoftheendometriumamultiinstitutionalcohortstudy
AT kefengmei systematiclymphadenectomyandoncologicaloutcomesofwomenwithapparentearlystageclearcellcarcinomaoftheendometriumamultiinstitutionalcohortstudy